Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
This study is currently recruiting participants.
Study NCT00794040 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 18, 2008 Last Updated: October 22, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mood Disorder
Additional conditions recognized in this trial
Attention Deficit and Disruptive Behavior Disorders
Attention Deficit Disorder with Hyperactivity
Disease
Hyperkinesis
Mental Disorders
Mental Disorders Diagnosed in Childhood
Mood Disorders
More general conditions related to this trial
Dyskinesias
Nervous System Diseases
Neurologic Manifestations
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
Citalopram
Methylphenidate
Additional drug interventions recognized in this trial
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute of Mental Health (NIMH)
Back to top of Main Content
